Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism FFAR2 antagonists(Free fatty acid receptor 2 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC20H20F3N5O2 |
InChIKeyAFMDUVFVMUUFKZ-INIZCTEOSA-N |
CAS Registry3034674-48-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Inflammation | Preclinical | DK | 11 May 2023 | |
Metabolic Diseases | Preclinical | DK | 11 May 2023 |